Cambridge Bioscience offers an extensive portfolio of products and services from leading manufacturing partners, to provide researchers with tools enabling better disease modelling for more physiologically relevant results in areas such as cancer research, precision medicine, and stem cell and gene-based therapies.
Our carefully selected range includes:
- High quality hiPSC derived cells for improved toxicity predictions in drug discovery
- Sophisticated technology for consumable-free cell counting
- Low toxicity transfection reagents supportive of any delivery method, capable of delivery of any nucleic acid into any cell type
- An extensive range of products for exosome research or engineering for biomarker discovery